Context Therapeutics Inc. - Common Stock, par value $0.001 per share (CNTX)

CUSIP: 21077P108

Q2 2022 13F Holders as of 30 Jun 2022

Holder snapshot 6 signals
Share change
-156,617
SEC-reported price per share
$2.12
Number of holders
17
Value change
-$388,653
Number of buys
12
Number of sells
5
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
92,789,000

Security key

21077P108

Report period

Q2 2022

Institutions

17

Top holders

10

Ownership snapshot

Top reported holders of CNTX - Context Therapeutics Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
SABBY MANAGEMENT, LLC
Comparable rows
0/14
Latest evidence
31 Mar 2022
13F 3/4/5 Highest disclosed value: $2,528,000 14 rows are not safely comparable across share classes. Showing 1-6 of 14 holder rows.

Quick read

SABBY MANAGEMENT, LLC has the largest disclosed position value at $2.53M.

0 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SABBY MANAGEMENT, LLC's linked filing trail.
Disclosed position value Top 5
SABBY MANAGEMENT, LLC $2.53M
Affinity Asset Advisors, LLC $1.69M
Worth Venture Partners, LLC $689K
VANGUARD GROUP INC $513K
Knoll Capital Management, LLC $303K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 14 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SABBY MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$2,528,000
1,165,100 shares
— 31 Mar 2022
Affinity Asset Advisors, LLC
13F
Company
13F
—
denominator unverified
$1,687,000
777,610 shares
— 31 Mar 2022
Worth Venture Partners, LLC
13F
Company
13F
—
denominator unverified
$689,000
317,729 shares
— 31 Mar 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$513,000
236,279 shares
— 31 Mar 2022
Knoll Capital Management, LLC
13F
Company
13F
—
denominator unverified
$303,000
139,520 shares
— 31 Mar 2022
Veritable, L.P.
13F
Company
13F
—
denominator unverified
$239,000
110,249 shares
— 31 Mar 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
17
Shares
2,747,803
Rows available
17
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2022 vs Q4 2025 Across Filers

Q4 2025 holders
42
Q2 2022 holders
17
Holder diff
-25
Investor Q4 2025 Shares Q2 2022 Shares Share Diff Share Chg % Q4 2025 value Q2 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .